文献速递慢性静脉疾病

慢性静脉疾病Freiburg生活质量评估简表(FLQA-VS-10)的心理测量学特性

Psychometric properties of the short version of the Freiburg Life Quality Assessment for chronic venous disease.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2021-09-14

本研究前瞻性招募100例接受介入治疗的复发性静脉曲张或静脉功能不全患者,在术前、术后及3年后两次间隔1周完成FLQA-VS-10及效标工具。结果显示FLQA-VS-10内部一致性高、无天花板效应但有地板效应、与效标工具相关性符合预期、重测信度ICC为0.92,患者认为易懂全面易完成。结论提示该简表可靠、有效、反应性好且可行。

要点

  • FLQA-VS-10在慢性静脉疾病患者中显示高内部一致性和重测信度(ICC 0.92)。
  • 该简表与静脉疾病特异性及通用HRQoL工具的相关性符合预期,反应性良好。
  • 术后评估中地板效应最高,但无天花板效应,患者认为条目易懂易完成。

核心结论

  • FLQA-VS-10是可靠、有效、反应性好且可行的慢性静脉疾病患者报告结局简表。

研究设计与样本

  • 前瞻性研究,招募100例接受介入静脉治疗的复发性静脉曲张或静脉功能不全患者。
  • 患者在术前、术后及3年后两次间隔1周完成FLQA-VS-10及效标工具。

主要发现

  • 平均年龄56.0±13.7岁,女性占66.0%。
  • FLQA-VS-10条目缺失值少,全局评分无天花板效应但有地板效应,术后评估时地板效应最高。
  • 全局评分各测量点内部一致性高,与效标工具相关性符合预期,重测信度ICC为0.92。
  • 患者认为FLQA-VS-10易懂、全面且易于完成。

临床怎么用

  • FLQA-VS-10可作为简短易用的工具评估慢性静脉疾病治疗中的患者报告结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic venous disease is a frequent vascular condition. International societies have recommended the use of health-related quality of life (HRQoL) instruments in the assessment of patients with vascular diseases. Thus, the Freiburg Life Quality Assessment for chronic venous disease, 10-item questionnaire (FLQA-VS-10) was developed. The aim of the present study was to validate the FLQA-VS-10 in a prospective study. METHODS: We recruited 100 patients with recurrent varicosis or incomplete or complete venous insufficiency undergoing interventional vein treatment (high ligation of the great or small saphenous vein or endovenous ablation therapy). These patients completed the FLQA-VS-10 and instruments assessing convergent validation criteria at four points: preoperatively (T1), postoperatively (T2) and twice 3 years later with a 1-week interval (T3 and T4). RESULTS: The mean age was 56.0 ± 13.7 years, and 66.0% were women. The patients had presented with recurrent varicosis of the saphenofemoral junction (28.0%), recurrent varicosis of the saphenopopliteal junction (1.0%), incomplete or complete insufficiency of the great saphenous vein (69.0%), or complete insufficiency of the small saphenous vein (2.0%). The items showed few missing values. The FLQA-VS-10 global score showed no ceiling effect (patients reporting the highest possible impairments in HRQoL) but did show a floor effect (patients reporting the lowest possible impairments in HRQoL), which was highest at the postoperative assessments. The internal consistency of the global score was high at all measurement points. A convergent validity and responsiveness analysis revealed that the FLQA-VS-10 correlated in the expected direction with the convergent instruments, including the Freiburg Life Quality Assessment for venous diseases (venous disease-specific HRQoL) and the five-level EQ-5D (generic HRQoL). Data from T3 and T4 revealed high test-retest reliability (intraclass correlation, 0.92). Overall, the patients stated that the FLQA-VS-10 was comprehensible, comprehensive, and easy to complete. CONCLUSIONS: Our data suggest that the FLQA-VS-10 is a reliable, valid, responsive, and feasible HRQoL questionnaire for patients with chronic venous diseases. This questionnaire can serve as short and easy-to-use instrument to assess patient-reported outcomes in the treatment of these patients.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Klein TM, Bal B, Newi AL, et al. Psychometric properties of the short version of the Freiburg Life Quality Assessment for chronic venous disease. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34530177. doi:10.1016/j.jvsv.2021.09.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。